MedPath

Study of Unani formulation in Itching in body

Phase 2
Conditions
Health Condition 1: null- Urticaria
Registration Number
CTRI/2018/02/011735
Lead Sponsor
ational Institute of Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All the clinically diagnosed cases of Chronic Urticaria.

Patients of either sexes in the age group of 20 to 50 years

Patients who have agreed to sign the informed written consent and follow the protocol.

Exclusion Criteria

Less than 20 and more than 50 years of age.

Well diagnosed cases of skin elements other than Urticaria.

Clearly defined underlying aetiology other than chronic Urticaria.

Other skin diseases like Psoriasis, Eczema. immunocompromised patients.

Patients suffering from any other systemic disorders like HTN, DM, IHD and HIV.

Pregnant and lactating women.

H/O Bronchial Asthma and Intestinal parasite and Anaphylaxis to medicine.

Patients on Systemic corticosteroid or immunosuppressive drug used in the past 6 weeks prior to the study

Unwillingness or inability to fulfill the protocol.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rticaria Activity Score (UAS 7) Score <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 0th day, 7th day, 14th day, 21st day and 28th day <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
CU-Q2OL <br/ ><br>Comparison of side effectsTimepoint: CU-Q2OL before and after treatment <br/ ><br>Comparison of side effects at 7th day, 14th day, 21st day and 28th day
© Copyright 2025. All Rights Reserved by MedPath